Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Synthetic porcine secretin
Trade Name: Secreflo
Date Designated: 03/07/2000
Orphan Designation: For use in conjunction with diagnostic, therapeutic, or combined diagnostic/therapeutic procedures for pancreatic disorders to increase pancreatic fluid secretion
Orphan Designation Status: Designated/Approved
ChiRhoClin, Inc.
15500 Gallaudet Ave.
Silver Spring, Maryland 20905
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Synthetic porcine secretin
Trade Name: Secreflo
Marketing Approval Date: 04/04/2002
Approved Labeled Indication: Use in secretin stimulation testing for stimulation of pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction
Exclusivity End Date: 04/04/2009 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-